(ANSA) – Rome, March 27 – Anti-malarial drugs chloroquine and hydroxychloroquine have been authorized in Italy to treat patients infected with Sars-Cov2, according to a
“Outside of a research protocol, use should be limited to patients whose clinical situation is severe, evaluated on a case-by-case basis, supported by an interdisciplinary
This is an excellent interview if you seek to understand the sickness. Dr Zelenko does an excellent pedagogic job here. And he explains how he
The title may seem exaggerated. Yet, it’s based on reality. Canadian research, has opted for self-screening and self-reporting, instead of letting people see a doctor. For
This summarizes pretty well the fate of the hydroxychloroquine azitromycin treatment, while there are numerous research programs now being started, with double blinded protocols. Researchers
There is an interesting opinion piece dated March 26 in the Globe and Mail, suggesting to give the hydroxychloroquine treatment a chance. At the same
See Facebook video
Eric Chabrière, one of the most renowned professors working with Professor Didier Raoult, comments the situation of the epidemic as of March 28 as well
“The UK should now be able to cope with the spread of the covid-19 virus, according to one of the epidemiologists advising the government.”Read more:
The former health minister pleads that hydroxychloroquine treatment be made available not only in hospitals, but also to general practitioners, given the emergency.
Former health minister, Philippe Douste-Blazy, advocates early treatment of patients.
Note: this article is dated March 28, just days after the RECOVERY trial was announced. See linked below the follow up to this article, dated